(Reuters) – The European Union drug regulator on Monday recommended authorisation for Pfizer Inc and BioNTech’s COVID-19 vaccine booster updated to target the BA.4 and BA.5 subvariants of Omicron.
The so-called bivalent vaccine targets both the subvariants, as well as the original strain of the virus.
(Reporting by Leroy Leo in Bengaluru; Editing by Vinay Dwivedi)
